GDD
MCID: GNT026
MIFTS: 45

Gnathodiaphyseal Dysplasia (GDD)

Categories: Bone diseases, Fetal diseases, Genetic diseases, Oral diseases, Rare diseases

Aliases & Classifications for Gnathodiaphyseal Dysplasia

MalaCards integrated aliases for Gnathodiaphyseal Dysplasia:

Name: Gnathodiaphyseal Dysplasia 56 12 52 25 58 73 36 29 13 6 15
Gdd 56 12 52 25 58 73
Osteogenesis Imperfecta with Unusual Skeletal Lesions 56 12 52 25 73
Osteogenesis Imperfecta, Levin Type 12 25 43 71
Gnathodiaphyseal Sclerosis 56 12 25 73
Levin Syndrome 2 12 52 25
Dysplasia, Gnathodiaphyseal 39

Characteristics:

Orphanet epidemiological data:

58
gnathodiaphyseal dysplasia
Inheritance: Autosomal dominant;

OMIM:

56
Inheritance:
autosomal dominant

Miscellaneous:
onset in first or second decade


HPO:

31
gnathodiaphyseal dysplasia:
Inheritance autosomal dominant inheritance


Classifications:

Orphanet: 58  
Rare bone diseases
Developmental anomalies during embryogenesis


External Ids:

Disease Ontology 12 DOID:0111533
OMIM 56 166260
KEGG 36 H00498
SNOMED-CT 67 715568002
Orphanet 58 ORPHA53697
MedGen 41 C1833736
UMLS 71 C1833736

Summaries for Gnathodiaphyseal Dysplasia

Genetics Home Reference : 25 Gnathodiaphyseal dysplasia is a disorder that affects the bones. People with this condition have reduced bone mineral density (osteopenia), which causes the bones to be unusually fragile. As a result, affected individuals typically experience multiple bone fractures in childhood, often from mild trauma or with no apparent cause. While most bone tissue is less dense than normal in gnathodiaphyseal dysplasia, the outer layer (cortex) of the shafts of the long bones in the arms and legs is abnormally hard and thick (diaphyseal sclerosis). Bowing of the long bones also occurs in this disorder. Jaw problems are common in gnathodiaphyseal dysplasia; the prefix "gnatho-" in the condition name refers to the jaw. Affected individuals may develop bone infections (osteomyelitis) in the jaw, which can lead to pain, swelling, discharge of pus from the gums, loose teeth, and slow healing after teeth are lost or extracted. Areas of the jawbone may lose the protective coverage of the gums, which can result in deterioration of the exposed bone (osteonecrosis of the jaw). Also, normal bone in areas of the jaw may be replaced by fibrous tissue and a hard material called cementum, which normally surrounds the roots of teeth and anchors them in the jaw. These areas of abnormal bone, called cementoosseous lesions, may be present at birth or develop later in life. When gnathodiaphyseal dysplasia was first described, it was thought to be a variation of another bone disorder called osteogenesis imperfecta, which is also characterized by frequent bone fractures. However, gnathodiaphyseal dysplasia is now generally considered to be a separate condition. Unlike in osteogenesis imperfecta, the fractures in gnathodiaphyseal dysplasia heal normally without causing deformity or loss of height.

MalaCards based summary : Gnathodiaphyseal Dysplasia, also known as gdd, is related to fibrous dysplasia and osteomyelitis. An important gene associated with Gnathodiaphyseal Dysplasia is ANO5 (Anoctamin 5), and among its related pathways/superpathways are Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds and Ion channel transport. Affiliated tissues include bone and cortex, and related phenotypes are bowing of the long bones and broad jaw

Disease Ontology : 12 An osteochondrodysplasia characterized by cementoosseous lesions of the jawbones, bone fragility, bowing/cortical thickening of tubular bones, and diaphyseal sclerosis of long bones that has material basis in heterozygous mutation in ANO5 on chromosome11p14.3.

NIH Rare Diseases : 52 The following summary is from Orphanet , a European reference portal for information on rare diseases and orphan drugs. Orpha Number: 53697 Definition Gnathodiaphyseal dysplasia (GDD) is a bone dysplasia characterized by bone fragility, frequent bone fractures at a young age, cemento-osseous lesions of the jaw bones, bowing of tubular bones (tibia and fibula) and diaphyseal sclerosis of long bones associated with generalized osteopenia. GD follows an autosomal dominant mode of transmission. Visit the Orphanet disease page for more resources.

OMIM : 56 Gnathodiaphyseal dysplasia is an autosomal dominant generalized skeletal syndrome characterized by cementoosseous lesions of the jawbones, in conjunction with bone fragility, bowing/cortical thickening of tubular bones, and diaphyseal sclerosis of long bones (summary by Marconi et al., 2013). (166260)

KEGG : 36 Gnathodiaphyseal dysplasia is a rare skeletal syndrome with autosomal dominant inheritance. It is characterized by cemento-osseous lesions of the jawbone, bone fragility, and sclerosis of tubular bones. Missense mutations of GDD1, which shows homology to TMEM16E, were identified.

UniProtKB/Swiss-Prot : 73 Gnathodiaphyseal dysplasia: Rare skeletal syndrome characterized by bone fragility, sclerosis of tubular bones, and cemento-osseous lesions of the jawbone. Patients experience frequent bone fractures caused by trivial accidents in childhood; however the fractures heal normally without bone deformity. The jaw lesions replace the tooth-bearing segments of the maxilla and mandible with fibrous connective tissues, including various amounts of cementum-like calcified mass, sometimes causing facial deformities. Patients also have a propensity for jaw infection and often suffer from purulent osteomyelitis-like symptoms, such as swelling of and pus discharge from the gums, mobility of the teeth, insufficient healing after tooth extraction and exposure of the lesions into the oral cavity.

Related Diseases for Gnathodiaphyseal Dysplasia

Graphical network of the top 20 diseases related to Gnathodiaphyseal Dysplasia:



Diseases related to Gnathodiaphyseal Dysplasia

Symptoms & Phenotypes for Gnathodiaphyseal Dysplasia

Human phenotypes related to Gnathodiaphyseal Dysplasia:

58 31 (show all 10)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 bowing of the long bones 58 31 hallmark (90%) Very frequent (99-80%) HP:0006487
2 broad jaw 58 31 hallmark (90%) Very frequent (99-80%) HP:0012802
3 thickened cortex of long bones 58 31 hallmark (90%) Very frequent (99-80%) HP:0000935
4 osteopenia 58 31 frequent (33%) Frequent (79-30%) HP:0000938
5 mandibular osteomyelitis 58 31 frequent (33%) Frequent (79-30%) HP:0007626
6 scoliosis 58 31 occasional (7.5%) Occasional (29-5%) HP:0002650
7 recurrent fractures 58 31 occasional (7.5%) Occasional (29-5%) HP:0002757
8 osteomyelitis 31 HP:0002754
9 increased susceptibility to fractures 31 HP:0002659
10 diaphyseal cortical sclerosis 31 HP:0005045

Symptoms via clinical synopsis from OMIM:

56
Skeletal:
osteopenia
bone fragility
jaw lesions show fibroblasts in fibrous stromal tissue

Head And Neck Face:
face deformity due to enlarged jaw bones

Skeletal Skull:
cemento-osseous lesions (maxilla and mandible)

Skeletal Limbs:
diaphyseal cortical sclerosis
leg bowing
diaphyseal bowing (radius, ulnae, tibiae, fibula)

Head And Neck Mouth:
jaw infection (osteomyelitis)

Clinical features from OMIM:

166260

MGI Mouse Phenotypes related to Gnathodiaphyseal Dysplasia:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 craniofacial MP:0005382 9.1 ANO6 BAMBI COL1A1 NELL1 OR51E2 SLC6A5

Drugs & Therapeutics for Gnathodiaphyseal Dysplasia

Search Clinical Trials , NIH Clinical Center for Gnathodiaphyseal Dysplasia

Cochrane evidence based reviews: osteogenesis imperfecta, levin type

Genetic Tests for Gnathodiaphyseal Dysplasia

Genetic tests related to Gnathodiaphyseal Dysplasia:

# Genetic test Affiliating Genes
1 Gnathodiaphyseal Dysplasia 29 ANO5

Anatomical Context for Gnathodiaphyseal Dysplasia

MalaCards organs/tissues related to Gnathodiaphyseal Dysplasia:

40
Bone, Cortex

Publications for Gnathodiaphyseal Dysplasia

Articles related to Gnathodiaphyseal Dysplasia:

(show all 38)
# Title Authors PMID Year
1
A novel missense mutation in ANO5/TMEM16E is causative for gnathodiaphyseal dyplasia in a large Italian pedigree. 61 6 56
23047743 2013
2
The novel gene encoding a putative transmembrane protein is mutated in gnathodiaphyseal dysplasia (GDD). 61 56 6
15124103 2004
3
[Familial cases of a new systemic bone disease, hereditary gnatho-diaphyseal sclerosis]. 6 56
5816667 1969
4
Autosomal dominant gnathodiaphyseal dysplasia maps to chromosome 11p14.3-15.1. 56 61
12619924 2003
5
Gnathodiaphyseal dysplasia: a syndrome of fibro-osseous lesions of jawbones, bone fragility, and long bone bowing. 56 61
11547842 2001
6
Osteogenesis imperfecta with unusual skeletal lesions: report of three families. 61 56
4014312 1985
7
Fragile bone syndrome associated with craniognathic fibro-osseous lesions and abnormal modeling of the tubular bones: report of two cases and review of the literature. 56
8958616 1996
8
Calvarial doughnut lesions with osteoporosis, multiple fractures, dentinogenesis imperfecta and tumorous changes in the jaws. (Report of a case). 56
6517811 1984
9
Gnathodiaphyseal dysplasia is not recapitulated in a respective mouse model carrying a mutation of the Ano5 gene. 61
32455153 2020
10
TMEM16E/ANO5 mutations related to bone dysplasia or muscular dystrophy cause opposite effects on lipid scrambling. 61
32112655 2020
11
Gnathodiaphyseal dysplasia with a novel R597I mutation of ANO5: Mandibular reconstruction strategies. 61
30641283 2019
12
Genetic Disruption of Anoctamin 5 in Mice Replicates Human Gnathodiaphyseal Dysplasia (GDD). 61
30712070 2019
13
Role of anoctamin 5, a gene associated with gnathodiaphyseal dysplasia, in osteoblast and osteoclast differentiation. 61
30557634 2019
14
Recurrent femoral shaft fractures in a child with gnathodiaphyseal dysplasia: a case report. 61
30797234 2019
15
Novel ANO5 mutation c.1067G>T (p.C356F) identified by whole genome sequencing in a big family with atypical gnathodiaphyseal dysplasia. 61
30554457 2019
16
Gain of function of TMEM16E/ANO5 scrambling activity caused by a mutation associated with gnathodiaphyseal dysplasia. 61
29124309 2018
17
A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation-prone Ano5 peptide. 61
29665321 2018
18
Prosthodontic Treatment of a Patient with Gnathodiaphyseal Dysplasia: 30-Year Follow-up. 61
29518808 2018
19
Gnathodiaphyseal dysplasia: Severe atypical presentation with novel heterozygous mutation of the anoctamin gene (ANO5). 61
29175271 2018
20
A Novel ANO5 Mutation Causing Gnathodiaphyseal Dysplasia With High Bone Turnover Osteosclerosis. 61
27541832 2017
21
Three novel ANO5 missense mutations in Caucasian and Chinese families and sporadic cases with gnathodiaphyseal dysplasia. 61
28176803 2017
22
Gnathodiaphyseal Dysplasia: Surgical Treatment and Prosthetic Rehabilitation of 2 Members of the Same Family. 61
27376179 2016
23
Gnathodiaphyseal dysplasia: report of a family with a novel mutation of the ANO5 gene. 61
27068316 2016
24
Whole exome sequencing links dental tumor to an autosomal-dominant mutation in ANO5 gene associated with gnathodiaphyseal dysplasia and muscle dystrophies. 61
27216912 2016
25
Modulating Ca²⁺ signals: a common theme for TMEM16, Ist2, and TMC. 61
26700940 2016
26
COL1A1 C-propeptide cleavage site mutation causes high bone mass, bone fragility and jaw lesions: a new cause of gnathodiaphyseal dysplasia? 61
24891183 2015
27
Gnathodiaphyseal dysplasia presenting as polyostotic fibrous dysplasia. 61
25866257 2015
28
Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy. 61
26693275 2015
29
Gnathodiaphyseal dysplasia. 61
24776605 2014
30
TMEM16E (GDD1) exhibits protein instability and distinct characteristics in chloride channel/pore forming ability. 61
23843187 2014
31
Recurring gnathodiaphyseal dysplasia in two Russian brothers. 61
20005074 2010
32
Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. 61
20096397 2010
33
Amphiregulin induces proliferative activities in osseous dysplasia. 61
19587163 2009
34
Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. 61
18805094 2008
35
Molecular characterization of GDD1/TMEM16E, the gene product responsible for autosomal dominant gnathodiaphyseal dysplasia. 61
17418107 2007
36
Gnathodiaphyseal dysplasia. 61
17189853 2007
37
Molecular cloning and characterization of the murine gnathodiaphyseal dysplasia gene GDD1. 61
15882990 2005
38
Characterization of human TMEM16G gene in silico. 61
15375614 2004

Variations for Gnathodiaphyseal Dysplasia

ClinVar genetic disease variations for Gnathodiaphyseal Dysplasia:

6 (show top 50) (show all 194) ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 ANO5 NM_213599.2(ANO5):c.1078T>C (p.Cys360Arg)SNV Pathogenic 437436 rs1554929292 11:22272351-22272351 11:22250805-22250805
2 ANO5 NM_213599.2(ANO5):c.299del (p.Arg100fs)deletion Pathogenic 418672 rs1064793358 11:22247534-22247534 11:22225988-22225988
3 ANO5 NM_213599.2(ANO5):c.412G>T (p.Glu138Ter)SNV Pathogenic 468828 rs1554924356 11:22248896-22248896 11:22227350-22227350
4 ANO5 NM_213599.2(ANO5):c.148C>T (p.Arg50Ter)SNV Pathogenic 468825 rs1168346560 11:22239801-22239801 11:22218255-22218255
5 ANO5 NM_213599.2(ANO5):c.220C>T (p.Arg74Ter)SNV Pathogenic 536729 rs749645231 11:22242682-22242682 11:22221136-22221136
6 ANO5 NM_213599.2(ANO5):c.1737dup (p.Gly580fs)duplication Pathogenic 578516 rs759064817 11:22283778-22283779 11:22262232-22262233
7 ANO5 NM_213599.2(ANO5):c.873_876del (p.Ile292fs)deletion Pathogenic 644214 11:22261223-22261226 11:22239677-22239680
8 ANO5 NM_213599.2(ANO5):c.775A>T (p.Lys259Ter)SNV Pathogenic 650336 11:22261127-22261127 11:22239581-22239581
9 ANO5 NM_213599.3(ANO5):c.1013+1G>ASNV Pathogenic 802663 11:22271918-22271918 11:22250372-22250372
10 ANO5 NC_000011.10:g.(?_22193483)_(22226062_?)deldeletion Pathogenic 830674 11:22215029-22247608
11 ANO5 NM_213599.2(ANO5):c.1066T>C (p.Cys356Arg)SNV Pathogenic 2161 rs119103234 11:22272339-22272339 11:22250793-22250793
12 ANO5 NM_213599.2(ANO5):c.1066T>G (p.Cys356Gly)SNV Pathogenic 2162 rs119103234 11:22272339-22272339 11:22250793-22250793
13 ANO5 NM_213599.2(ANO5):c.1295C>G (p.Ala432Gly)SNV Pathogenic 2163 rs137854524 11:22277031-22277031 11:22255485-22255485
14 ANO5 NM_213599.2(ANO5):c.41-1G>ASNV Pathogenic 96685 rs398124625 11:22225349-22225349 11:22203803-22203803
15 ANO5 NM_001142649.2(ANO5):c.986dup (p.Leu329fs)duplication Pathogenic 96688 rs398124626 11:22271891-22271892 11:22250345-22250346
16 ANO5 NM_213599.3(ANO5):c.2272C>T (p.Arg758Cys)SNV Pathogenic 2166 rs137854529 11:22296151-22296151 11:22274605-22274605
17 ANO5 NM_213599.2(ANO5):c.1541C>T (p.Thr514Ile)SNV Pathogenic 60689 rs397514736 11:22281198-22281198 11:22259652-22259652
18 ANO5 NM_213599.2(ANO5):c.1733T>C (p.Phe578Ser)SNV Pathogenic 140553 rs137854526 11:22283777-22283777 11:22262231-22262231
19 ANO5 NM_213599.2(ANO5):c.2018A>G (p.Tyr673Cys)SNV Pathogenic 140555 rs137854527 11:22291977-22291977 11:22270431-22270431
20 ANO5 NM_213599.2(ANO5):c.1520del (p.Phe507fs)deletion Pathogenic 194577 rs794727158 11:22281176-22281176 11:22259630-22259630
21 ANO5 NM_213599.2(ANO5):c.1898+1G>ASNV Pathogenic 194805 rs142027093 11:22284590-22284590 11:22263044-22263044
22 ANO5 NM_213599.2(ANO5):c.304_308del (p.Lys102fs)deletion Pathogenic 280322 rs776859202 11:22247535-22247539 11:22225989-22225993
23 ANO5 NM_213599.2(ANO5):c.2004del (p.Leu669fs)deletion Pathogenic 285669 rs886043172 11:22291961-22291961 11:22270415-22270415
24 ANO5 NM_213599.2(ANO5):c.1627dup (p.Met543fs)duplication Pathogenic 285942 rs281865480 11:22281279-22281280 11:22259733-22259734
25 ANO5 NM_213599.2(ANO5):c.1213C>T (p.Gln405Ter)SNV Pathogenic/Likely pathogenic 285742 rs368970223 11:22276949-22276949 11:22255403-22255403
26 ANO5 NM_213599.2(ANO5):c.139-1deldeletion Pathogenic/Likely pathogenic 286467 rs868484837 11:22239791-22239791 11:22218245-22218245
27 ANO5 NM_213599.2(ANO5):c.762+1G>ASNV Pathogenic/Likely pathogenic 217144 rs372221490 11:22257823-22257823 11:22236277-22236277
28 ANO5 NM_001142649.2(ANO5):c.188dup (p.Asn63fs)duplication Pathogenic/Likely pathogenic 2164 rs137854521 11:22242646-22242647 11:22221100-22221101
29 ANO5 NM_213599.2(ANO5):c.692G>T (p.Gly231Val)SNV Pathogenic/Likely pathogenic 2165 rs137854523 11:22257752-22257752 11:22236206-22236206
30 ANO5 NM_213599.2(ANO5):c.1088G>A (p.Trp363Ter)SNV Pathogenic/Likely pathogenic 504242 rs1554929301 11:22272361-22272361 11:22250815-22250815
31 ANO5 NM_213599.2(ANO5):c.1120-1G>ASNV Pathogenic/Likely pathogenic 536726 rs561719071 11:22272496-22272496 11:22250950-22250950
32 ANO5 NM_213599.2(ANO5):c.1955A>G (p.Tyr652Cys)SNV Pathogenic/Likely pathogenic 432005 rs563666662 11:22291914-22291914 11:22270368-22270368
33 ANO5 NM_213599.3(ANO5):c.860_863dup (p.Leu289fs)duplication Likely pathogenic 804457 11:22261210-22261211 11:22239664-22239665
34 ANO5 NC_000011.10:g.(?_22272764)_(22276219_?)deldeletion Likely pathogenic 583864 11:22294310-22297765 11:22272764-22276219
35 ANO5 NM_213599.2(ANO5):c.295-1G>ASNV Likely pathogenic 569608 rs780109230 11:22247529-22247529 11:22225983-22225983
36 ANO5 NC_000011.10:g.(?_22218246)_(22221210_?)deldeletion Likely pathogenic 584414 11:22239792-22242756 11:22218246-22221210
37 ANO5 NC_000011.10:g.(?_22218236)_(22221220_?)deldeletion Likely pathogenic 833229 11:22239782-22242766
38 ANO5 NC_000011.10:g.(?_22272774)_(22276209_?)deldeletion Likely pathogenic 831952 11:22294320-22297755
39 ANO5 NM_213599.3(ANO5):c.1029C>T (p.Asp343=)SNV Conflicting interpretations of pathogenicity 96677 rs78899595 11:22272302-22272302 11:22250756-22250756
40 ANO5 NM_213599.2(ANO5):c.2259A>G (p.Ser753=)SNV Conflicting interpretations of pathogenicity 128389 rs61746201 11:22296138-22296138 11:22274592-22274592
41 ANO5 NM_213599.2(ANO5):c.2688C>G (p.Ala896=)SNV Conflicting interpretations of pathogenicity 263315 rs377549896 11:22301257-22301257 11:22279711-22279711
42 ANO5 NM_213599.2(ANO5):c.680G>C (p.Gly227Ala)SNV Conflicting interpretations of pathogenicity 282496 rs140903276 11:22257740-22257740 11:22236194-22236194
43 ANO5 NM_213599.2(ANO5):c.259G>A (p.Val87Ile)SNV Conflicting interpretations of pathogenicity 282497 rs34994927 11:22242721-22242721 11:22221175-22221175
44 ANO5 NM_213599.2(ANO5):c.2521-1deldeletion Conflicting interpretations of pathogenicity 283199 rs752982710 11:22301089-22301089 11:22279543-22279543
45 ANO5 NM_213599.2(ANO5):c.720G>T (p.Leu240=)SNV Conflicting interpretations of pathogenicity 283939 rs147121216 11:22257780-22257780 11:22236234-22236234
46 ANO5 NM_213599.2(ANO5):c.2498T>A (p.Met833Lys)SNV Conflicting interpretations of pathogenicity 285338 rs142073798 11:22297723-22297723 11:22276177-22276177
47 ANO5 NM_213599.2(ANO5):c.369G>A (p.Ser123=)SNV Conflicting interpretations of pathogenicity 285474 rs199888040 11:22248853-22248853 11:22227307-22227307
48 ANO5 NM_213599.2(ANO5):c.2256G>A (p.Thr752=)SNV Conflicting interpretations of pathogenicity 285552 rs144048656 11:22296135-22296135 11:22274589-22274589
49 ANO5 NM_213599.2(ANO5):c.2503_2505del (p.Phe835del)deletion Conflicting interpretations of pathogenicity 195634 rs794727350 11:22297727-22297729 11:22276181-22276183
50 ANO5 NM_213599.2(ANO5):c.2521C>G (p.His841Asp)SNV Conflicting interpretations of pathogenicity 195705 rs781027702 11:22301090-22301090 11:22279544-22279544

UniProtKB/Swiss-Prot genetic disease variations for Gnathodiaphyseal Dysplasia:

73
# Symbol AA change Variation ID SNP ID
1 ANO5 p.Cys356Gly VAR_023524 rs119103234
2 ANO5 p.Cys356Arg VAR_023525 rs119103234
3 ANO5 p.Cys356Tyr VAR_076476

Expression for Gnathodiaphyseal Dysplasia

Search GEO for disease gene expression data for Gnathodiaphyseal Dysplasia.

Pathways for Gnathodiaphyseal Dysplasia

GO Terms for Gnathodiaphyseal Dysplasia

Biological processes related to Gnathodiaphyseal Dysplasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 transmembrane transport GO:0055085 10.03 SLC17A6 ANO9 ANO7 ANO6 ANO5 ANO3
2 ion transmembrane transport GO:0034220 9.91 ANO9 ANO7 ANO6 ANO5 ANO3 ANO2
3 chloride transport GO:0006821 9.8 ANO9 ANO7 ANO6 ANO5 ANO2 ANO10
4 lipid transport GO:0006869 9.76 ANO9 ANO7 ANO6 ANO3
5 calcium activated phosphatidylserine scrambling GO:0061589 9.58 ANO9 ANO7 ANO6
6 calcium activated galactosylceramide scrambling GO:0061591 9.56 ANO9 ANO7 ANO6 ANO3
7 calcium activated phosphatidylcholine scrambling GO:0061590 9.46 ANO9 ANO7 ANO6 ANO3
8 calcium activated phospholipid scrambling GO:0061588 9.26 ANO9 ANO7 ANO6 ANO3
9 chloride transmembrane transport GO:1902476 9.17 ANO9 ANO7 ANO6 ANO5 ANO3 ANO2

Molecular functions related to Gnathodiaphyseal Dysplasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein dimerization activity GO:0046983 9.65 ANO7 ANO6 ANO5 ANO3 ANO2
2 phospholipid scramblase activity GO:0017128 9.46 ANO9 ANO7 ANO6 ANO3
3 chloride channel activity GO:0005254 9.43 ANO9 ANO7 ANO6 ANO5 ANO3 ANO2
4 calcium activated cation channel activity GO:0005227 9.32 ANO6 ANO10
5 intracellular calcium activated chloride channel activity GO:0005229 9.17 ANO9 ANO7 ANO6 ANO5 ANO3 ANO2

Sources for Gnathodiaphyseal Dysplasia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....